AMN Healthcare Reports Strong Q4 2025 Earnings with Labor Disruption Revenue Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 20 2026
0mins
Should l Buy AMN?
Source: seekingalpha
AMN Healthcare's stock rose by 10.71% as it reached a 5-day high, reflecting positive market sentiment following its earnings report.
The company reported Q4 2025 revenue of $748 million, a 2% year-over-year increase, and $18 million above guidance, driven by robust performance in labor disruption revenue. Although the adjusted EBITDA decreased by 27% year-over-year, the net loss improved significantly from $188 million last year to $8 million, indicating effective cost control. Management's optimistic outlook for Q1 2026 revenue, projected between $1.225 billion and $1.24 billion, further supports confidence in future growth despite anticipated gross margin impacts.
This strong performance highlights AMN's resilience in a competitive healthcare market and its strategic investments in AI technology to enhance operational efficiency, positioning the company for sustainable growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMN
Wall Street analysts forecast AMN stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.190
Low
22.00
Averages
23.50
High
25.00
Current: 20.190
Low
22.00
Averages
23.50
High
25.00
About AMN
AMN Healthcare Services, Inc. is a provider of total talent solutions for healthcare organizations across the United States. The Company provides access to a comprehensive network of quality healthcare professionals through its recruitment strategies and breadth of career opportunities. Its segments include nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. The nurse and allied solutions segment include its travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing businesses. The physician and leadership solutions segment includes its locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company’s language services, vendor management systems (VMS), workforce optimization, and outsourced solutions businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AMN Healthcare Schedules Q1 2026 Earnings Call
- Earnings Call Scheduled: AMN Healthcare has scheduled a conference call for May 7, 2026, at 5:00 PM ET to discuss its Q1 2026 financial results and Q2 outlook, reflecting the company's commitment to transparency and investor communication.
- Earnings Release Timing: The company plans to issue its earnings news release on the same day at approximately 4:15 PM, allowing investors to access critical information promptly for informed decision-making.
- Webcast Availability: The call will be accessible via a live webcast, which can be found on the company's investor relations website, enhancing information accessibility and demonstrating the company's focus on investor engagement.
- Healthcare Leadership Position: In 2025, AMN Healthcare served over 13 million patients across more than 2,300 healthcare systems, underscoring its leadership and innovation in the healthcare sector, thereby solidifying its competitive advantage in the market.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Healthcare Executives See Confidence Gap Amid Industry Challenges
- Widening Confidence Gap: Nearly three-quarters of healthcare executives believe their organizations will be as strong or stronger in 2026, yet over half expect the overall industry to face a worse year, indicating a significant divergence in confidence that could impact investment and strategic decisions.
- Surge in AI Leadership Demand: With 63% of executives citing the need for a clear AI strategy, 48% emphasizing clinician and staff engagement for adoption, and 41% focusing on data infrastructure investment, the rising importance of AI in leadership is poised to transform healthcare delivery.
- Cooling Retention Risks: While 35% of leaders are considering leaving within a year, the report notes a reduced urgency to move compared to previous years, potentially giving organizations more time to enhance employee retention strategies.
- Limited Advancement Opportunities: Only 21% of respondents feel they are on a promotion track, while 26% believe they must leave their employer to advance, highlighting a significant issue with limited internal promotion opportunities that may lead to talent attrition.
See More
AMN Healthcare Reports Strong Q4 2025 Earnings with Labor Disruption Revenue Surge
- Strong Financial Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase and $18 million above guidance, indicating robust performance in labor disruption revenue that is expected to drive future growth.
- EBITDA and Net Loss: While adjusted EBITDA was $54 million, down 27% year-over-year, the net loss improved significantly from $188 million last year to $8 million, reflecting substantial progress in cost control and operational optimization.
- Optimistic Outlook: The company projects Q1 2026 revenue between $1.225 billion and $1.24 billion, with approximately $600 million from labor disruption support, demonstrating confidence in future market demand, although gross margin is expected to be impacted by 300 basis points.
- Accelerated Technology Investment: Management emphasized investments in AI technology to enhance efficiency in non-clinical patient interactions, indicating strategic decisions to adapt to market changes and improve service quality, aiming for sustainable organic revenue growth of 4% to 6% in the future.
See More
AMN Healthcare Reports Q4 2025 Revenue of $748 Million Amid Losses
- Quarterly Revenue Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% increase year-over-year but an 8% decline compared to the previous year, indicating intensified market competition and operational challenges.
- Net Loss Situation: The company recorded a net loss of $7.7 million, or $0.20 per share, which is an improvement from a net loss of $188 million in the same quarter last year, reflecting efforts in cost control.
- Adjusted EPS: Adjusted diluted EPS was $0.22, down 70% from $0.75 in the prior year, highlighting ongoing pressure on profitability and the need for stronger business transformation.
- Debt Reduction and Cash Flow: The company reduced debt by $75 million in 2025, with cash flow from operations totaling $269 million, demonstrating positive progress in financial management despite declining overall revenue, maintaining a degree of financial flexibility.
See More
AMN Healthcare Services Q4 Earnings Analysis
- Earnings Report: AMN Healthcare Services reported a Q4 non-GAAP EPS of $0.22, missing expectations by $0.05, indicating pressure on profitability that may affect investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $748.2 million, a 1.8% year-over-year increase, exceeding market expectations by $24.79 million, demonstrating resilience in a competitive healthcare services market.
- Cash Flow Status: Operating cash flow for the quarter was $76 million, with an annual total of $269 million, reflecting robust financial management that supports future investments and expansion.
- Debt Reduction: AMN reduced its debt by $75 million in the quarter, bringing the total debt reduction for the year to $285 million, significantly improving the company's financial structure and enhancing future financial flexibility.
See More
AMN Healthcare Schedules Q1 2026 Earnings Call
- Earnings Call Scheduled: AMN Healthcare has scheduled a conference call for May 7, 2026, at 5:00 PM ET to discuss its Q1 2026 financial results and Q2 outlook, reflecting the company's commitment to transparency and investor communication.
- Earnings Release Timing: The company plans to issue its earnings news release on the same day at approximately 4:15 PM, allowing investors to access critical information promptly for informed decision-making.
- Webcast Availability: The call will be accessible via a live webcast, which can be found on the company's investor relations website, enhancing information accessibility and demonstrating the company's focus on investor engagement.
- Healthcare Leadership Position: In 2025, AMN Healthcare served over 13 million patients across more than 2,300 healthcare systems, underscoring its leadership and innovation in the healthcare sector, thereby solidifying its competitive advantage in the market.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Healthcare Executives See Confidence Gap Amid Industry Challenges
- Widening Confidence Gap: Nearly three-quarters of healthcare executives believe their organizations will be as strong or stronger in 2026, yet over half expect the overall industry to face a worse year, indicating a significant divergence in confidence that could impact investment and strategic decisions.
- Surge in AI Leadership Demand: With 63% of executives citing the need for a clear AI strategy, 48% emphasizing clinician and staff engagement for adoption, and 41% focusing on data infrastructure investment, the rising importance of AI in leadership is poised to transform healthcare delivery.
- Cooling Retention Risks: While 35% of leaders are considering leaving within a year, the report notes a reduced urgency to move compared to previous years, potentially giving organizations more time to enhance employee retention strategies.
- Limited Advancement Opportunities: Only 21% of respondents feel they are on a promotion track, while 26% believe they must leave their employer to advance, highlighting a significant issue with limited internal promotion opportunities that may lead to talent attrition.
See More
AMN Healthcare Reports Strong Q4 2025 Earnings with Labor Disruption Revenue Surge
- Strong Financial Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase and $18 million above guidance, indicating robust performance in labor disruption revenue that is expected to drive future growth.
- EBITDA and Net Loss: While adjusted EBITDA was $54 million, down 27% year-over-year, the net loss improved significantly from $188 million last year to $8 million, reflecting substantial progress in cost control and operational optimization.
- Optimistic Outlook: The company projects Q1 2026 revenue between $1.225 billion and $1.24 billion, with approximately $600 million from labor disruption support, demonstrating confidence in future market demand, although gross margin is expected to be impacted by 300 basis points.
- Accelerated Technology Investment: Management emphasized investments in AI technology to enhance efficiency in non-clinical patient interactions, indicating strategic decisions to adapt to market changes and improve service quality, aiming for sustainable organic revenue growth of 4% to 6% in the future.
See More
AMN Healthcare Reports Q4 2025 Revenue of $748 Million Amid Losses
- Quarterly Revenue Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% increase year-over-year but an 8% decline compared to the previous year, indicating intensified market competition and operational challenges.
- Net Loss Situation: The company recorded a net loss of $7.7 million, or $0.20 per share, which is an improvement from a net loss of $188 million in the same quarter last year, reflecting efforts in cost control.
- Adjusted EPS: Adjusted diluted EPS was $0.22, down 70% from $0.75 in the prior year, highlighting ongoing pressure on profitability and the need for stronger business transformation.
- Debt Reduction and Cash Flow: The company reduced debt by $75 million in 2025, with cash flow from operations totaling $269 million, demonstrating positive progress in financial management despite declining overall revenue, maintaining a degree of financial flexibility.
See More
AMN Healthcare Services Q4 Earnings Analysis
- Earnings Report: AMN Healthcare Services reported a Q4 non-GAAP EPS of $0.22, missing expectations by $0.05, indicating pressure on profitability that may affect investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $748.2 million, a 1.8% year-over-year increase, exceeding market expectations by $24.79 million, demonstrating resilience in a competitive healthcare services market.
- Cash Flow Status: Operating cash flow for the quarter was $76 million, with an annual total of $269 million, reflecting robust financial management that supports future investments and expansion.
- Debt Reduction: AMN reduced its debt by $75 million in the quarter, bringing the total debt reduction for the year to $285 million, significantly improving the company's financial structure and enhancing future financial flexibility.
See More
